new glp 1 drugs in development Novo cuts GLP-1 prices 70%, but semaglutide revenue could grow 2026 Frontiers | Beyond GLP-1: underexplored
Description
After standardizing for various factors, GLP1 RA compared with metformin was associated with reduced 1year risk of addon glucoselowering treatment in patients with prediabetes (1year risk ratio [RR]: 0.27, 95% confidence interval [CI]: 0.100.44) and diabetes (RR: 0.67, 95% CI: 0.370.98)
These data strongly suggest that GLP-1R agonists are beneficial to attenuate neuroinflammation-associated cognitive impairment and thereby improve cognition
[DOI] [PMC free article] [PubMed] [Google Scholar] 78
Profit before tax rose by 3% to 130.5bn kroner
How Fast Does Amazon Deliver GLP-1 Medications
